Poly Medicure Ltd. witnessed a 3% surge in its share price during morning trade following the release of its robust Q4 results. The company reported impressive year-on-year growth across key financial metrics for the quarter. As of 10:06 AM, the shares were trading 3.37% higher at Rs 2,875.00.
For Q4, Poly Medicure posted a 16.6% increase in revenue, reaching Rs 441 crore compared to Rs 378 crore in the same period last year. The company’s EBITDA saw a notable rise of 23.8%, amounting to Rs 119 crore, up from Rs 96 crore last year. This improvement in profitability was further reflected in the company’s EBITDA margin, which expanded to 27%, compared to 25.5% in the previous year.
Poly Medicure’s net profit also soared by 35.3%, reaching Rs 92 crore as compared to Rs 68 crore in Q4 FY24, demonstrating strong operational efficiency and market demand.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
